Glucagon-like peptide-2 vs Motilin
Head-to-head comparison of Glucagon-like peptide-2 (Glucagon-like peptide-2) and Motilin (Motilin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Glucagon-like peptide-2 | Motilin |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Glucagon-like peptide-2 | Motilin |
| Molecular Weight | ~3.7 kDa | ~2.7 kDa |
| Half-Life | ~7 min | ~20 min |
| Amino Acids | 33 | 22 |
| Typical Dose | Research-only dosing varies; native peptide is not routinely used clinically | No standard approved dose; experimental use only |
| Route | SC|IV | IV|SC |
| Purity | ≥98% | ≥98% |
| Studies Count | 90 | 81 |
| Research Status | Endogenous | Endogenous |
Glucagon-like peptide-2 Benefits
- ✓mucosal trophic support
- ✓intestinal barrier repair
- ✓nutrient absorption support
Motilin Benefits
- ✓migrating motor complex support
- ✓gastric emptying
- ✓small-bowel clearance
Glucagon-like peptide-2 Dosing
0.5–2 mg/day (research)|SC/IV
Motilin Dosing
0.1–1 mg (experimental)|IV/SC
Glucagon-like peptide-2 Side Effects
- ⚠nausea
- ⚠abdominal fullness
Motilin Side Effects
- ⚠cramping
- ⚠nausea
Research Overview
Glucagon-like peptide-2
Native GLP-2 is a key enteric growth factor with rapid degradation by DPP-4. Its therapeutic value is best known through GLP-2 analog development, but the native peptide itself is a real GI-relevant hormone.
Motilin
Motilin is a 22-amino-acid peptide released from the upper small intestine and is one of the classic physiologic prokinetic signals. It is a real peptide target for GI motility research, though not commonly used as a standard drug.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.